Companies Dominating the Precision Oncology Landscape
- Illumina, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific Inc.
- Roche Holding AG
- Qiagen N.V.
- Foundation Medicine, Inc.
- Guardant Health, Inc.
- Myriad Genetics, Inc.
- Agilent Technologies, Inc.
- Personalis, Inc.
- NeoGenomics Laboratories, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Precision Oncology Market in 2025 is evaluated at USD 126.04 billion.
The global market size was over USD 116.53 billion in 2024 and is anticipated to witness a CAGR of around 10.2%, crossing USD 411.91 billion revenue by 2037.
Asia Pacific is expected to achieve USD 177.12 billion by 2037, driven by rising cancer incidence rates and the increasing demand for personalized cancer care solutions.
The major players in the market include Illumina, Inc., Thermo Fisher Scientific Inc., Roche Holding AG, Qiagen N.V., Foundation Medicine, Inc., Guardant Health, Inc., Myriad Genetics, Inc., Agilent Technologies, Inc., Personalis, Inc., NeoGenomics Laboratories, Inc.
